Paris - Delayed Quote • EUR
Sanofi (SAN.PA)
At close: 5:39 PM GMT+2
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 9 | 7 | 24 | 24 |
Avg. Estimate | 1.72 | 1.62 | 7.69 | 8.77 |
Low Estimate | 1.57 | 1.51 | 6.98 | 8.06 |
High Estimate | 1.8 | 1.74 | 8.86 | 10 |
Year Ago EPS | 2.16 | 1.74 | 8.11 | 7.69 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 9 | 6 | 23 | 23 |
Avg. Estimate | 10.4B | 10.72B | 47.08B | 50.33B |
Low Estimate | 10.12B | 10.42B | 44.75B | 47.35B |
High Estimate | 10.91B | 11.24B | 49.95B | 53.55B |
Year Ago Sales | 10.28B | -- | 43.07B | 47.08B |
Sales Growth (year/est) | 1.10% | -- | 9.30% | 6.90% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 2.01 | 1.67 | 2.58 | 1.68 |
EPS Actual | 2.16 | 1.74 | 2.55 | 1.66 |
Difference | 0.15 | 0.07 | -0.03 | -0.02 |
Surprise % | 7.50% | 4.20% | -1.20% | -1.20% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 1.72 | 1.62 | 7.69 | 8.77 |
7 Days Ago | 1.71 | 1.6 | 7.71 | 8.75 |
30 Days Ago | 1.73 | 1.63 | 7.73 | 8.77 |
60 Days Ago | 1.75 | 1.68 | 7.83 | 8.85 |
90 Days Ago | 1.78 | 1.68 | 7.93 | 8.92 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | 2 | 2 |
Up Last 30 Days | -- | -- | 4 | 5 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | 1 | -- | 3 | 2 |
Growth Estimates
CURRENCY IN USD | SAN.PA | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -20.40% | -- | -- | 1.50% |
Next Qtr. | -6.90% | -- | -- | 11.40% |
Current Year | -5.20% | -- | -- | 5.20% |
Next Year | 14.00% | -- | -- | 13.40% |
Next 5 Years (per annum) | 6.11% | -- | -- | 11.09% |
Past 5 Years (per annum) | 10.20% | -- | -- | -- |
Research Analysis
Related Tickers
NOVN.SW Novartis AG
90.00
+0.99%
ROG.SW Roche Holding AG
218.80
-1.53%
BAYN.DE Bayer Aktiengesellschaft
26.90
-0.28%
GSK.L GSK plc
1,640.50
+0.28%
AZN.L AstraZeneca PLC
12,026.00
+5.94%
REC.MI Recordati Industria Chimica e Farmaceutica S.p.A.
48.80
-2.36%
RO.SW Roche Holding AG
236.80
-1.00%
GRF.MC Grifols, S.A.
8.09
-3.46%
NVS Novartis AG
98.93
+0.59%
VIRP.PA Virbac SA
346.50
-3.75%